Filing metadata

Accession number
0001859061-23-000006
Form type
Form 4
Filer
A2A Pharmaceuticals, Inc.
CIK
CIK 1859061
Filed
May 17, 2023
Reporting period
May 12, 2023
Description
Insider transaction

Explore SEC Filings Hub